Search

Pages

1. • Journal article

   • 

   Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy

   Van Cutsem, Eric Joulain, Florence Hoff, Paulo M Mitchell, Edith Ruff, Paul Lakomý, Radek Prausová, Jana Moiseyenko, Vladimir M van Hazel, Guy Cunningham, David Arnold, Dirk Schmoll, Hans-Joachim Ten Tije, Albert J McKendrick, Joseph Kröning, Hendrik Humblet, Yves[UCL] Grávalos, Cristina Le-Guennec, Solenn Andria, Michael Dochy, Emmanuelle Vishwanath, Raghu L Macarulla, Teresa Tabernero, Josep (2016) Targeted Oncology : biotherapies for the clinicians in oncology — Vol. 11, no. 3, p. 383-400 (2016)
2. • Journal article

   • 

   European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer

   Lordick, Florian Ruers, Theo Aust, Daniela E. Collette, Laurence[UCL] Downey, Robert J. El Hajjam, Mostafa Flameng, Patrick Haustermans, Karen Ilson, David Julie, Catherine Krause, Bernd Joachim Newiger, Hartwig Ott, Katja Roth, Arnaud Van Cutsem, Eric[UCL] Weber, Wolfgang A. Lutz, Manfred P. (2008) European Journal of Cancer — Vol. 44, no. 13, p. 1807-1819 (2008)
3. • Journal article

   • 

   A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma.

   Dekervel, Jeroen Popovic, Dusan van Malenstein, Hannah Windmolders, Petra Heylen, Line Libbrecht, Louis[UCL] Bulle, Ashenafi De Moor, Bart Van Cutsem, Eric Nevens, Frederik Verslype, Chris van Pelt, Jos (2016) Translational Oncology (Online) — Vol. 9, no.2, p. 139-146 (2016)
4. • Journal article

   • 

   A seven-gene set associated with chronic hypoxia of prognostic importance in hepatocellular carcinoma

   van Malenstein, Hannah Gevaert, Olivier Libbrecht, Louis[UCL] Daemen, Anneleen Allemeersch, Joke Nevens, Frederik Van Cutsem, Eric Cassiman, David De Moor, Bart Verslype, Chris van Pelt, Jos (2010) Clinical Cancer Research — Vol. 16, no.16, p. 4278-4288 (2010)
5. • Journal article

   • 

   Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study

   Van Cutsem, Eric Tejpar, Sabine Vanbeckevoort, Dirk Peeters, Marc Humblet, Yves[UCL] Gelderblom, Hans Vermorken, Jan B Viret, Frederic Glimelius, Bengt Gallerani, Elisa Hendlisz, Alain Cats, Annemieke Moehler, Markus Sagaert, Xavier Vlassak, Soetkin Schlichting, Michael Ciardiello, Fortunato (2012) Journal of Clinical Oncology — Vol. 30, no.23, p. 2861-2868 (2012)
6. • Journal article

   • 

   Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.

   Tabernero, Josep Yoshino, Takayuki Cohn, Allen Lee Obermannova, Radka Bodoky, Gyorgy Garcia-Carbonero, Rocio Ciuleanu, Tudor-Eliade Portnoy, David C Van Cutsem, Eric Grothey, Axel Prausová, Jana Garcia-Alfonso, Pilar Yamazaki, Kentaro Clingan, Philip R Lonardi, Sara Kim, Tae Won Simms, Lorinda Chang, Shao-Chun Nasroulah, Federico RAISE Study Investigators Van den Eynde, Marc[UCL] Humblet, Yves[UCL] (2015) The Lancet Oncology — Vol. 16, p. 499-508 (2015)
7. • Journal article

   • 

   Corrigendum to "Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?" (vol 42, pg 42, 2006)

   Efficace, Fabio Bottomley, Andrew Coens, Corneel Van Steen, Kristel Conroy, Thierry Schoeffski, Patrick Schmoll, Hans Van Cutsem, Eric[UCL] Koehne, Claus-Henning (2007) European Journal of Cancer — Vol. 43, no. 3, p. 633-633 (2007)
8. • Journal article

   • 

   Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).

   Ricotta, Riccardo Verrioli, Antonella Ghezzi, Silvia Porcu, Luca Grothey, A Falcone, Alfredo Van Cutsem, Eric Argilés, Guillem Adenis, Antoine Ychou, Marc Barone, Carlo Bouché, Olivier Peeters, Marc Humblet, Yves[UCL] Mineur, Laurent Sobrero, Alberto F Hubbard, Joleen M Cremolini, Chiara Prenen, Hans Tabernero, Josep Jarraya, Hajer Mazard, Thibault Deguelte-Lardiere, Sophie Papadimitriou, Konstantinos Van den Eynde, Marc[UCL] Pastorino, Alessandro Redaelli, Daniela Bencardino, Katia Funaioli, Chiara Amatu, Alessio Carlo-Stella, Giulia Torri, Valter Sartore-Bianchi, Andrea Vanzulli, Angelo Siena, Salvatore (2017) ESMO Open — Vol. 1, no. 6, p. e000111 [1-10] (2017)
9. • Journal article

   • 

   Molecular test algorithms for digestive tumours

   Hébrant, Aline Mourin, Anne[UCL] Froyen, Guy Van der Meulen, Joni de Man, Marc Salgado, Roberto Van den Eynde, Marc[UCL] D'haene, Nicky Martens, Geert Van Cutsem, Eric Antoine-Poirel, Hélène[UCL] Tejpar, Sabine Van Laethem, Jean-Luc Geboes, Karen Pauwels, Patrick Dedeurwaerdere, Francesca Maes, Brigitte De Greve, Jacques Vanhuysse, Jacques Peeters, Pascal Vanacker, Leen Gomez-Galdon, Maria Chintinne, Marie Hendlisz, Alain De Hertogh, Gert Sagaert, Xavier Peeters, Marc Vannuffel, Pascal Lefesvre, Pierre Vermeij, Joanna Simoens, Marc Van den Moorter, Tom Van Damme, Nancy Van den Bulcke Marc (2019) Belgian Journal of Medical Oncology — Vol. 13, no.1, p. 4-10 (2019)
10. • Journal article

    • 

    Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard?

    Veereman, Geneviève Vlayen, Joan Robays, Jo Fairon, Nicolas Stordeur, Sabine Rolfo, Christian Bielen, Didier Bols, Alain Demetter, Pieter D'hoore, André Haustermans, Karin Hendlisz, Alain Lemmers, Arnaud Léonard, Daniel[UCL] Penninckx, Freddy Van Cutsem, Eric Peeters, Marc (2017) Critical Reviews in Oncology / Hematology — Vol. 114, p. 43-52 (2017)
11. • Journal article

    • 

    Combined BRAF, EGFR, and MEK Inhibition in Patients with -Mutant Colorectal Cancer.

    Corcoran, Ryan B André, Thierry Atreya, Chloe E Schellens, Jan H M Yoshino, Takayuki Bendell, Johanna C Hollebecque, Antoine McRee, Autumn J Siena, Salvatore Middleton, Gary Muro, Kei Gordon, Michael S Tabernero, Josep Yaeger, Rona O'Dwyer, Peter J Humblet, Yves[UCL] De Vos, Filip Jung, A Scott Brase, Jan C Jaeger, Savina Bettinger, Severine Mookerjee, Bijoyesh Rangwala, Fatima Van Cutsem, Eric (2018) Cancer discovery — Vol. 8, no.4, p. 428-443 (2018)
12. • Journal article

    • 

    Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.

    Hendlisz, Alain Van den Eynde, Marc[UCL] Peeters, Marc Maleux, Geert Lambert, Bieke Vannoote, Jaarke De Keukeleire, Katrien Verslype, Chris Defreyne, Luc Van Cutsem, Eric Delatte, Philippe Delaunoit, Thierry Personeni, Nicola Paesmans, Marianne Van Laethem, Jean-Luc Flamen, Patrick (2010) Journal of Clinical Oncology — Vol. 28, no. 23, p. 3687-3694 (2010)
13. • Journal article

    • 

    Defunctioning stoma and anastomotic leak rate after total mesorectal excision with coloanal anastomosis in the context of PROCARE.

    Beirens, Koen Penninckx, Freddy PROCARE Bertrand, Claude[UCL] Kartheuser, Alex[UCL] Scalliet, Pierre[UCL] Jouret-Mourin, Anne[UCL] Sempoux, Christine[UCL] Humblet, Yves[UCL] Van Cutsem, Eric[UCL] Danse, Etienne[UCL] Rahier, Jacques[UCL] (2012) Acta Chirurgica Belgica (Bilingual Edition) — Vol. 112, no. 1, p. 10-14 (2012)
14. • Speech

    • 

    Cetuximab dose-escalation study in patients with metastatic colorectal cancer (MCRC) with no or slight skin reactions on cetuximab standard dose treatment (Everest): Preliminary PK and efficacy data of a randomized study

    Van Cutsem, Eric Humblet, Yves[UCL] Gelderblom, Hans Vermorken, Jan B. Viret, Frederic Glimelius, Bengt Ciardiello, Fortunato Gallerani, Elisa Kisker, Oliver Peeters, Marc (2006) 30th Congress of the European-Society-for-Medical-Oncology — Istanbul (Turkey)
15. • Journal article

    • 

    Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer

    Peeters, Marc Oliner, Kelly S Parker, Alex Siena, Salvatore Van Cutsem, Eric Huang, Jing Humblet, Yves[UCL] Van Laethem, Jean-Luc André, Thierry Wiezorek, Jeffrey Reese, David Patterson, Scott D (2013) Clinical Cancer Research — Vol. 19, no.7, p. 1902-1912 (2013)
16. • Journal article

    • 

    The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin

    Hompes, Daphne D'Hoore, André Van Cutsem, Eric Fieuws, Steffen Ceelen, Wim Peeters, Marc Van der Speeten, Kurt Bertrand, Claude[UCL] Legendre, Hugues[UCL] Kerger, Joseph[UCL] (2012) Annals of Surgical Oncology — Vol. 19, no. 7, p. 2186-2194 (2012)
17. • Speech

    • 

    DUSP4 expression level in colorectal primaries predicts overall survival benefit in Kras wild-type and Kras mutant colorectal cancer after treatment with cetuximab for metastatic disease

    De Roock, Wendy Janssens, Marc Biesmans, Bart Jacobs, Bart De Schutter, Jef Humblet, Yves[UCL] Peeters, Marc Van Cutsem, Eric Marynen, Peter Tejpar, Sabine (2008) 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics — (Switzerland) Geneva
18. • Journal article

    • 

    Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    Grothey, Axel Van Cutsem, Eric Sobrero, Alberto Siena, Salvatore Falcone, Alfredo Ychou, Marc Humblet, Yves[UCL] Bouché, Olivier Mineur, Laurent Barone, Carlo Adenis, Antoine Tabernero, Josep Yoshino, Takayuki Lenz, Heinz-Josef Goldberg, Richard M Sargent, Daniel J Cihon, Frank Cupit, Lisa Wagner, Andrea Laurent, Dirk CORRECT Study Group (2013) The Lancet — Vol. 381, no.9863, p. 303-12 (2013)
19. • Journal article

    • 

    Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer.

    Bulle, Ashenafi Dekervel, Jeroen Deschuttere, Lise Nittner, David Libbrecht, Louis[UCL] Janky, Rekin's Plaisance, Stéphane Topal, Baki Coosemans, An Lambrechts, Diether Van Cutsem, Eric Verslype, Chris van Pelt, Jos (2020) Translational oncology — Vol. 13, no.3, p. 100743 [1-10] (2020)
20. • Speech

    • 

    Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer

    Tabernero, Josep Van Cutsem, Eric Díaz-Rubio, Eduardo Cervantes, Andrés Humblet, Yves[UCL] Andre, Thierry Van Laethem, Jean-Luc Soulie, Patrick Casado, Esther Verslype, Chris Valera, Javier Sastre Tortora, Giampaolo Ciardiello, Fortunato Kisker, Oliver de Gramont, Aimery (2007) The American Society of Clinical Oncology Gastrointestinal Symposium — Orlando(Fl)
21. • Journal article

    • 

    Cost-effectiveness of cetuximab in combination with irinotecan compared with current care in metastatic colorectal cancer after failure on irinotecan : A Belgian analysis

    Annemans, L. Van Cutsem, Eric Humblet, Yves[UCL] Van Laethem, Jean-Luc Bleiberg, H. (2007) Acta Clinica Belgica (Multilingual Edition) — Vol. 62, no. 6, p. 419-425 (2007)
22. • Journal article

    • 

    Association of progression-free survival with patient-reported outcomes and survival : results from a randomised phase 3 trial of panitumumab.

    Siena, S. Peeters, M. Van Cutsem, Eric Humblet, Yves[UCL] Conte, P. Bajetta, E. Comandini, D. Bodoky, G. Van Hazel, G. Salek, T. Wolf, M. Devercelli, G. Woolley, M. Amado, R.G. (2007) The British journal of cancer — Vol. 97, no. 11, p. 1469-74 (2007)
23. • Speech

    • 

    Pimasertib plus gemcitabine in metastatic pancreatic adenocarcinoma: Results of a safety run-in part of a phase II trial.

    Verslype, Chris Hammel, Pascal Hidalgo, Manuel Macarulla, Teresa Garcia-Carbonero, Rocio André, Thierry Van den Eynde, Marc[UCL] Laquente Saez, Berta Milella, Michele Raymond, Eric Faivre, Thea Milner, Alvin Tarabaric, Dolores Locatelli, Giuseppe von Richter, Oliver Laffranchi, Bernard Van Cutsem, Eric (2013) 2013 ASCO Annual Meeting — (United States) Chicago, IL
24. • Journal article

    • 

    Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: A retrospective, exploratory analysis of the CORRECT trial

    Tabernero, Josep Lenz, Heinz-Josef Siena, Salvatore Sobrero, Alberto Falcone, Alfredo Ychou, Marc Humblet, Yves[UCL] Bouché, Olivier Mineur, Laurent Barone, Carlo Adenis, Antoine Yoshino, Takayuki Goldberg, Richard M. Sargent, Daniel J. Wagner, Andrea Laurent, Dirk Teufel, Michael Jeffers, Michael Grothey, Axel Van Cutsem, Eric (2015) The Lancet Oncology — Vol. 16, no. 8, p. 937-948 (2015)
25. • Journal article

    • 

    Double blind randomized phase II study with radiation+5-fluorouracil+/-celecoxib for resectable rectal cancer

    Debucquoy, Annelies Roels, Sarah Goethals, Laurence Libbrecht, Louis[UCL] Van Cutsem, Eric Geboes, Karel Penninckx, Freddy D'Hoore, André McBride, William H Haustermans, Karin (2009) Radiotherapy & Oncology — Vol. 93, no.2, p. 273-278 (2009)

Pages